Nearly all our medical research is wrong
What do we know about the state of life sciences and medical research? It’s a $200B market, takes an entire decade to bring a new medicine to market, and has a serious issue of lack of reproducibility (like when a biotech giant found only 11% of 53 landmark cancer studies could be confirmed.)
That's why we're thrilled to back Misfit and AgaMatrix co-founder Sridhar Iyengar's latest endeavor, Elemental Machines, which announced their $2.5M round and suite of connected lab products to better track scientific experiments—already cutting research time by 6+ months for some customers.
Headlines
Reproducibility: A Tragedy Of Errors
Tweet | Nature
Latest Telemedicine Bill Could Save $1.8B By Waiving Medicare Restrictions
Tweet | MobiHealthNews
Study: Doctors’ Texts Can Prod Patients To Take Drugs, But Questions Linger
Tweet | Kaiser Health News
Telemedicine Advances Faster Than States Can Keep Up
Tweet | Governing
Hospitals Focus On Doing No Harm
Tweet | The New York Times
Can Gizmos Cure Insomnia?
Tweet | The New Yorker
ACA Enrollment Pleases HHS. Insurers Will Be Tougher Crowd
Tweet | Modern Healthcare
Rock Health in the News
Doctor On Demand Adds Psychiatry Visits
Tweet | MobiHealthNews
Hospital’s Mobile Health Project Finds Value In Fitbit Data
Tweet | mHealthIntelligence
Rock Health Tackles The Opportunities And Challenges Of Digital Biomarkers
Tweet | MobiHealthNews
Funding
| Company | Amt | Investors | Source |
| Pear Therapeutics | $20M | 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Bridge Builders Collaborative | MedCity News |
| Elemental Machines | $2.5M | Founders Fund, Max Levchin, Project 11 Ventures, 2M Companies, Rock Health | TechCrunch |
Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.